22.08.2025
С. Н. Переходов; Н. Ю. Сакварелидзе; С. Г. Цахилова; Е. В. Лунина
, it was decided to reassign medical institutions to infectious hospitals for the treatment of patients with COVID
22.08.2025
А. Н. Цибин; М. Ф. Латыпова; О. И. Иванушкина
an acute infectious disease predominantly affecting the lungs (Corona Virus Disease 2019, COVID-19
22.08.2025
Д. О. Драгунов; А. В. Соколова; А. Д. Гасанова; Т. В. Латышев; Г. П. Арутюнов
Purpose. Analysis of the incidence of COVID-19 in patients from the register «Management
22.08.2025
Yu. А. Kuznetsova; Ю. А. Кузнецова; А. V. Smirnova; А. В. Смирнова
(foreign, local), phases and disease areas. Separately COVID-19 clinical trials were considered. Conclusion
22.08.2025
П. Д. Панков; М. Х. Салпагаров; Н. Н. Яковлева
(SARS-CoV-2) and introduce a modified treatment method for COVID-19-associated pneumonia. X-ray therapy
20.08.2025
О. В. Масалкина; Н. А. Козиолова; К. И. Белоусов
developed questionnaire, taking into account the relationship with COVID‑19 infection.
Results. The mean age
20.08.2025
С. А. Бондарь; О. П. Ротарь; М. А. Бояринова; Е. В. Могучая; Е. П. Колесова; А. М. Ерина; Е. Ю. Васильева; А. В. Березина; Т. Л. Каронова; А. О. Конради
of decreased exercise tolerance in patients after COVID‑19.
Objective. To evaluate the structural
19.08.2025
О. А. Разуваев
of mycoplasma pneumonia was 13.9% and 5.3%, respectively. The first increase in the incidence of COVID-19
17.08.2025
Е. О. Ряднова; В. П. Кицышин
in patients with novel coronavirus infection (COronaVIrus Disease 2019, COVID-19).
Material and methods
13.08.2025
А. В. Богачева; Н. И. Кокина; О. Ю. Зольникова; Э. Р. Буклис; М. А. Татаркина; А. П. Кирюхин; М. В. Фельдшеров; Е. А. Коган; В. Т. Ивашкин
, and spleen. Background disease: New coronavirus infection COVID-19 from January 2022. Prolonged
